GJIA
VKTX icon

Glass Jacobson Investment Advisors’s Viking Therapeutics VKTX Stock Holding History

Glass Jacobson Investment Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.5K Hold
1,063
– – 0.01% 352
2026
Q1 		$34.6K Hold
1,063
– – 0.01% 358
2025
Q4 		$37.4K Hold
1,063
– – 0.01% 339
2025
Q3 		$27.9K Hold
1,063
– – 0.01% 363
2025
Q2 		$28.2K Buy
+1,063
New +$28K 0.01% 350
2024
Q4 		– Sell
-375
Closed -$23.7K – 871
2024
Q3 		$23.7K Hold
375
– – 0.01% 470
2024
Q2 		$19.9K Hold
375
– – 0.01% 484
2024
Q1 		$30.8K Buy
+375
New +$16.7K 0.01% 426

Other funds holding VKTX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
LA
LBP AM Paris, France $10B AUM 43.88% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Glass Jacobson Investment Advisors's VKTX Position: Q2 2026 in Review

Glass Jacobson Investment Advisors held its Viking Therapeutics (VKTX) position steady in Q2 2026 at 1,063 shares worth $41.5K. The position accounts for 0.01% of the portfolio, ranked #352.

Glass Jacobson Investment Advisors first reported a position in VKTX in Q1 2024 and has held it in 8 quarters since. 124 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Glass Jacobson Investment Advisors held 1,063 shares of Viking Therapeutics worth $41.5K as of Q2 2026.
  • Glass Jacobson Investment Advisors left its Viking Therapeutics share count unchanged in Q2 2026.
  • Viking Therapeutics made up 0.01% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #352 holding.
  • Glass Jacobson Investment Advisors first reported a position in Viking Therapeutics in Q1 2024 and has held it in 8 quarters since.
  • 124 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.